EFFICACY AND SAFETY OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOCUSING ON PATIENTS WITH DIABETIC MACULAR EDEMA FROM JAPAN

PURPOSE: To evaluate the efficacy and safety of intravitreal aflibercept injection (IAI) in Japanese patients with diabetic macular edema (DME). METHODS: VIVID-DME was a Phase 3 study comprising patients with DME randomized 1:1:1 to IAI 2 mg every 4 weeks (2q4), IAI 2 mg every 4 weeks until Week 16...

Descripción completa

Detalles Bibliográficos
Autores principales: Terasaki, Hiroko, Shiraki, Kunihiko, Ohji, Masahito, Metzig, Carola, Schmelter, Thomas, Zeitz, Oliver, Sowade, Olaf, Kobayashi, Masato, Vitti, Robert, Berliner, Alyson, Shiraga, Fumio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Retina 2019
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510325/
https://www.ncbi.nlm.nih.gov/pubmed/29470308
http://dx.doi.org/10.1097/IAE.0000000000002100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510325/
https://www.ncbi.nlm.nih.gov/pubmed/29470308
http://dx.doi.org/10.1097/IAE.0000000000002100

Ejemplares similares